MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis
about
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis
description
scientific article published on 24 May 2020
@en
name
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis
@en
type
label
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis
@en
prefLabel
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis
@en
P2093
P50
P356
P1433
P1476
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis
@en
P2093
Dominik Schneidawind
Hannes Schmid
Hildegard Keppeler
Johan Jeong
Kathy-Ann Secker
Silke Duerr-Stoerzer
P356
10.3390/CANCERS12051342
P577
2020-05-24T00:00:00Z